Principles for evidence-based drug formulary policy
نویسندگان
چکیده
منابع مشابه
3-tier drug benefit designs based on sound drug formulary principles will maximize favorable outcomes.
■■ 3-Tier Drug Benefit Designs Based on Sound Drug Formulary Principles Will Maximize Favorable Outcomes Employer-sponsored drug benefit plans have embraced the 3-tier drug benefit design in dramatic fashion, with 63% of covered workers subject to a 3-tier copay design in 2003 compared with 27% just 3 years earlier (in 2000) and 55% in 2002. Use of the 2-tier copay design, the predominant drug ...
متن کامل2 Evidence - based policy : principles and requirements
Evidence-based policy (EBP) is an aspiration rather than an accomplished outcome. The advocates of EBP urge the incorporation of rigorous research evidence into public policy debates and internal public sector processes for policy evaluation and program improvement. The primary goal is to improve the reliability of advice concerning the efficiency and effectiveness of policy settings and possib...
متن کاملEvidence-based and value-based formulary guidelines.
Health plans and hospitals have long used drug formularies, but the processes by which formulary committees made decisions have typically lacked transparency and scientific rigor. A growing number of organizations have begun implementing formulary guidelines issued by the Academy of Managed Care Pharmacy (AMCP). These guidelines call for health plans to request formally that drug companies pres...
متن کاملRethinking antipsychotic formulary policy.
In this commentary, we review recent research suggesting that (a) second-generation antipsychotics (SGAs) may be no more effective than first-generation antipsychotics (FGAs), (b) the reduced risk of EPS and tardive dyskinesia with SGAs is more weakly supported by the research literature than has been appreciated, and (c) benefits may be offset by greater metabolic risks of some SGAs and their ...
متن کاملFormulary Drug Reviews
INDICATIONS AND BACKGROUND Ibuprofen lysine is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1,500 g who are no more than 32 weeks gestational age when usual medical management (fluid restriction, diuretics, respiratory support, etc.) is ineffective. Indomethacin injection is indicated for the treatment of PDA in prematu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of General Internal Medicine
سال: 2005
ISSN: 0884-8734,1525-1497
DOI: 10.1111/j.1525-1497.2005.0232.x